NovaBay Pharmaceuticals, Inc. (NBY)
NYSEAMERICAN: NBY · Real-Time Price · USD
0.5702
0.00 (0.00%)
Apr 25, 2025, 4:00 PM EDT - Market closed
NovaBay Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 0.43 | 2.92 | 5.36 | 7.5 | 11.95 | Upgrade
|
| Cash & Short-Term Investments | 0.43 | 2.92 | 5.36 | 7.5 | 11.95 | Upgrade
|
| Cash Growth | -85.29% | -45.47% | -28.54% | -37.22% | 72.29% | Upgrade
|
| Accounts Receivable | 0.39 | 0.68 | 1.97 | 1.67 | 1.11 | Upgrade
|
| Receivables | 0.39 | 0.68 | 1.97 | 1.67 | 1.11 | Upgrade
|
| Inventory | 0.77 | 0.5 | 3.65 | 3.59 | 0.61 | Upgrade
|
| Prepaid Expenses | 0.19 | 0.26 | 0.19 | 0.27 | 0.36 | Upgrade
|
| Other Current Assets | 0.16 | 2.79 | 0.16 | 0.14 | 0.21 | Upgrade
|
| Total Current Assets | 1.94 | 7.15 | 11.33 | 13.17 | 14.24 | Upgrade
|
| Property, Plant & Equipment | 1.01 | 1.38 | 1.95 | 0.6 | 0.52 | Upgrade
|
| Goodwill | - | - | 0.35 | 4.53 | - | Upgrade
|
| Other Intangible Assets | - | - | 2.28 | 5.2 | - | Upgrade
|
| Other Long-Term Assets | 0.48 | 0.5 | 0.49 | 0.48 | 0.48 | Upgrade
|
| Total Assets | 3.42 | 9.03 | 16.4 | 23.98 | 15.24 | Upgrade
|
| Accounts Payable | 0.62 | 0.91 | 1.08 | 1.05 | 0.3 | Upgrade
|
| Accrued Expenses | 0.77 | 1.17 | 0.92 | 0.8 | 1.19 | Upgrade
|
| Short-Term Debt | 0.57 | 1.14 | - | 0.11 | - | Upgrade
|
| Current Portion of Leases | 0.4 | 0.37 | 0.45 | 0.2 | 0.42 | Upgrade
|
| Current Unearned Revenue | 0.49 | - | 1.81 | 1.29 | 0.73 | Upgrade
|
| Other Current Liabilities | - | 0.7 | - | - | 0.2 | Upgrade
|
| Total Current Liabilities | 2.84 | 4.28 | 4.26 | 3.44 | 2.83 | Upgrade
|
| Long-Term Leases | 0.71 | 1.11 | 1.59 | 0.25 | 0.09 | Upgrade
|
| Other Long-Term Liabilities | - | 0.33 | - | 10.12 | - | Upgrade
|
| Total Liabilities | 3.55 | 5.72 | 5.85 | 13.81 | 2.92 | Upgrade
|
| Common Stock | 0.05 | 0 | 0.02 | 0.48 | 0.42 | Upgrade
|
| Additional Paid-In Capital | 183.27 | 176.21 | 165.71 | 150.9 | 147.96 | Upgrade
|
| Retained Earnings | -183.46 | -174.85 | -158.15 | -141.89 | -136.06 | Upgrade
|
| Total Common Equity | -0.14 | 1.36 | 7.58 | 9.49 | 12.32 | Upgrade
|
| Shareholders' Equity | -0.13 | 3.31 | 10.55 | 10.17 | 12.32 | Upgrade
|
| Total Liabilities & Equity | 3.42 | 9.03 | 16.4 | 23.98 | 15.24 | Upgrade
|
| Total Debt | 1.67 | 2.61 | 2.04 | 0.55 | 0.5 | Upgrade
|
| Net Cash (Debt) | -1.24 | 0.31 | 3.32 | 6.95 | 11.45 | Upgrade
|
| Net Cash Growth | - | -90.64% | -52.24% | -39.27% | 296.02% | Upgrade
|
| Net Cash Per Share | -0.37 | 2.59 | 72.20 | 195.15 | 399.85 | Upgrade
|
| Filing Date Shares Outstanding | 5.82 | 0.86 | 0.06 | 0.04 | 0.03 | Upgrade
|
| Total Common Shares Outstanding | 4.89 | 0.32 | 0.06 | 0.04 | 0.03 | Upgrade
|
| Working Capital | -0.91 | 2.88 | 7.08 | 9.73 | 11.41 | Upgrade
|
| Book Value Per Share | -0.03 | 4.25 | 130.36 | 243.40 | 361.15 | Upgrade
|
| Tangible Book Value | -0.14 | 1.36 | 4.95 | -0.24 | 12.32 | Upgrade
|
| Tangible Book Value Per Share | -0.03 | 4.25 | 85.17 | -6.08 | 361.15 | Upgrade
|
| Machinery | 0.59 | 0.61 | 0.59 | 0.76 | 0.61 | Upgrade
|
| Leasehold Improvements | 0.15 | 0.15 | 0.15 | 0.08 | 0.08 | Upgrade
|
Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.